COCP
COCRYSTAL PHARM (COCP)
NASDAQ
$1.06+$0.01 (+0.95%)
Price as of Jun 03, 2026 5:59 PM EDT
  • $15.4M
    Market Cap
  • -37.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
564,000
-74.36%
2.2M
-27.87%
3.0M
N/A
N/A
N/A
Gross Profit
-564,000
-74.36%
-2.2M
-27.87%
-3.0M
N/A
0
-100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-5.1M
-59.68%
-12.5M
-17.35%
-15.2M
+22.41%
-12.4M
+40.91%
Depreciation and Amortization Expense
72,000
-42.86%
126,000
-33.33%
189,000
+2.16%
185,000
-2.63%
Total Operating Expenses
9.0M
-49.55%
17.9M
-3.67%
18.6M
-52.20%
38.8M
+173.04%
Operating Profit
-9.0M
-49.55%
-17.9M
-3.67%
-18.6M
-52.20%
-38.8M
+173.04%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-640,000
+31,900.00%
-2,000
-50.00%
Interest Income and Expense and Net
0
N/A
0
+100.00%
-640,000
+31,900.00%
-2,000
-50.00%
Total Nonoperating Income and Expense
188,000
-49.73%
374,000
-34.96%
575,000
+7,287.50%
-8,000
-122.22%
Income before Taxes
-9.0M
-49.55%
-17.9M
-3.67%
-18.6M
-52.20%
-38.8M
+173.04%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
19.1M
N/A
Net Income
N/A
N/A
N/A
N/A
-18.0M
-53.69%
-38.8M
+173.79%
Net Income from Continuing Operations Applicable to Common
-8.8M
N/A
N/A
N/A
-18.0M
-53.69%
-38.8M
+173.79%
Basic EPS and Net Income
-0.78
-54.65%
-1.72
-8.02%
-1.87
-60.80%
-4.77
+2,881.25%
Diluted EPS and Net Income
-0.78
-54.65%
-1.72
-8.02%
-1.87
-60.80%
-4.77
+2,881.25%
Basic Weighted Average Shares
11.3M
+10.97%
10.2M
+5.42%
9.7M
+18.52%
8.1M
-90.79%
Diluted Weighted Average Shares
11.3M
+10.97%
10.2M
+5.42%
9.7M
+18.52%
8.1M
-90.79%
Balance Sheet
Cash and Cash Equivalents
7.1M
-28.54%
9.9M
-62.41%
26.4M
-28.99%
37.2M
-36.65%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.1M
-28.54%
9.9M
-62.41%
26.4M
-28.99%
37.2M
-36.65%
Total Current Assets
14.1M
-28.75%
19.7M
-53.80%
42.7M
-42.61%
74.4M
-36.69%
Accumulated Depreciation
2.0M
+3.73%
1.9M
+6.99%
1.8M
+11.71%
1.6M
+12.95%
Property and Plant and Equipment and Net
93,000
-39.22%
153,000
-43.54%
271,000
-20.76%
342,000
-24.50%
Total Long-Term Assets
93,000
-39.22%
153,000
-43.54%
271,000
-20.76%
342,000
-24.50%
Total Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.2M
-9.68%
4.6M
-40.82%
7.8M
+330.02%
1.8M
-26.83%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
1.6M
-51.40%
3.3M
-4.47%
3.5M
+898.85%
347,000
-56.13%
Total Liabilities
104,000
-93.09%
1.5M
-6.70%
1.6M
+2,729.82%
57,000
-80.41%
Retained Earnings
-342.2M
+2.65%
-333.4M
N/A
N/A
N/A
N/A
N/A
Total Stockholders Equity
6.3M
-33.52%
9.5M
-63.91%
26.4M
-33.32%
39.6M
-48.98%
Total Shares Outstanding
13.8M
+35.48%
10.2M
0.00%
10.2M
+24.94%
8.1M
-91.65%
Cash Flow
Cash from Operating Activities
-8.2M
-50.31%
-16.5M
+12.40%
-14.7M
-31.58%
-21.4M
+68.53%
Capital Expenditures
12,000
+50.00%
8,000
-93.22%
118,000
+59.46%
74,000
+42.31%
Cash from Investing Activities
-12,000
+50.00%
-8,000
-93.22%
-118,000
+59.46%
-74,000
+42.31%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.4M
N/A
N/A
N/A
4.0M
+14,888.89%
-27,000
-100.07%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
-54.54%
-17.77%
-66.32%
+204.04%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.35
-21.11%
4.25
-21.93%
5.45
-86.65%
40.81
-13.48%
Cash Ratio
1.70
-20.87%
2.14
-36.48%
3.37
-83.49%
20.43
-13.43%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow